These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21486263)

  • 1. Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma Study: implications for posttrial implementation.
    Pinto RM; Campbell AN; Hien DA; Yu G; Gorroochurn P
    Am J Orthopsychiatry; 2011 Apr; 81(2):211-7. PubMed ID: 21486263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network.
    Marsch LA; Campbell A; Campbell C; Chen CH; Ertin E; Ghitza U; Lambert-Harris C; Hassanpour S; Holtyn AF; Hser YI; Jacobs P; Klausner JD; Lemley S; Kotz D; Meier A; McLeman B; McNeely J; Mishra V; Mooney L; Nunes E; Stafylis C; Stanger C; Saunders E; Subramaniam G; Young S
    J Subst Abuse Treat; 2020 Mar; 112S():4-11. PubMed ID: 32220409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection.
    Potter JS; Donovan DM; Weiss RD; Gardin J; Lindblad R; Wakim P; Dodd D
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):400-7. PubMed ID: 21854283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing ethnic minority participation in substance abuse clinical trials: lessons learned in the National Institute on Drug Abuse's Clinical Trials Network.
    Burlew K; Larios S; Suarez-Morales L; Holmes B; Venner K; Chavez R
    Cultur Divers Ethnic Minor Psychol; 2011 Oct; 17(4):345-56. PubMed ID: 21988575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.
    Susukida R; Crum RM; Stuart EA; Ebnesajjad C; Mojtabai R
    Addiction; 2016 Jul; 111(7):1226-34. PubMed ID: 26825855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study results from the Clinical Trials Network's first 10 years: where do they lead?
    Wells EA; Saxon AJ; Calsyn DA; Jackson TR; Donovan DM
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S14-30. PubMed ID: 20307792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network.
    Burlew AK; Weekes JC; Montgomery L; Feaster DJ; Robbins MS; Rosa CL; Ruglass LM; Venner KL; Wu LT
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):324-32. PubMed ID: 21854274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future.
    Carroll KM; Ball SA; Jackson R; Martino S; Petry NM; Stitzer ML; Wells EA; Weiss RD
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):275-82. PubMed ID: 21854269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design and analysis of multisite effectiveness trials: a decade of progress in the National Drug Abuse Clinical Trials Network.
    Nunes EV
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):269-72. PubMed ID: 21854267
    [No Abstract]   [Full Text] [Related]  

  • 10. Technology transfer for the implementation of a clinical trials network on drug abuse and mental health treatment in Mexico.
    Horigian VE; Marín-Navarrete RA; Verdeja RE; Alonso E; Perez MA; Fernández-Mondragón J; Berlanga C; Medina-Mora ME; Szapocznik J
    Rev Panam Salud Publica; 2015 Sep; 38(3):233-42. PubMed ID: 26758002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of an evidence-based parenting intervention for integration into maternal-child home-visiting programs: Challenges and solutions.
    Peacock-Chambers E; Moran M; Clark MC; Borelli JL; Byatt N; Friedmann PD; Suchman NE; Feinberg E
    Implement Res Pract; 2023; 4():. PubMed ID: 36873580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peer-based Retention Of people who Use Drugs in Rural Research (PROUD-R
    Young AM; Lancaster KE; Bielavitz S; Elman MR; Cook RR; Leichtling G; Freeman E; Estadt AT; Brown M; Alexander R; Barrie C; Conn K; Elzaghal R; Maybrier L; McDowell R; Neal C; Lapidus J; Waddell EN; Korthuis PT
    BMJ Open; 2022 Jun; 12(6):e064400. PubMed ID: 35705346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of therapeutic alliance, treatment feedback, and clinical outcomes among African American women in treatment for co-occurring PTSD and SUD.
    Bauer AG; Ruglass LM; Shevorykin A; Saraiya TC; Robinson G; Cadet K; Julien L; Chao T; Hien D
    J Subst Abuse Treat; 2022 Aug; 139():108766. PubMed ID: 35346534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeing the forest for the trees: Predicting attendance in trials for co-occurring PTSD and substance use disorders with a machine learning approach.
    López-Castro T; Zhao Y; Fitzpatrick S; Ruglass LM; Hien DA
    J Consult Clin Psychol; 2021 Oct; 89(10):869-884. PubMed ID: 34807661
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis.
    Santo T; Campbell G; Gisev N; Tran LT; Colledge S; Di Tanna GL; Degenhardt L
    Drug Alcohol Depend; 2021 Feb; 219():108459. PubMed ID: 33401031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying and responding to trial implementation challenges during multisite clinical trials.
    Greer TL; Walker R; Rethorst CD; Northrup TF; Warden D; Horigian VE; Silverstein M; Shores-Wilson K; Stotts AL; Trivedi MH
    J Subst Abuse Treat; 2020 Mar; 112S():63-72. PubMed ID: 32220413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "Women and Trauma" study and its national impact on advancing trauma specific approaches in community substance use treatment and research.
    Hien D; Kropp F; Wells EA; Campbell A; Hatch-Maillette M; Hodgkins C; Killeen T; Lopez-Castro T; Morgan-Lopez A; Ruglass LM; Saavedra L; Nunes EV
    J Subst Abuse Treat; 2020 Mar; 112S():12-17. PubMed ID: 32220405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment processes and demographic variables as predictors of dropout from trauma-focused cognitive behavioral therapy (TF-CBT) for youth.
    Yasinski C; Hayes AM; Alpert E; McCauley T; Ready CB; Webb C; Deblinger E
    Behav Res Ther; 2018 Aug; 107():10-18. PubMed ID: 29800623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: A randomized controlled trial.
    Schacht RL; Brooner RK; King VL; Kidorf MS; Peirce JM
    J Consult Clin Psychol; 2017 Jul; 85(7):689-701. PubMed ID: 28414485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.
    Roberts NP; Roberts PA; Jones N; Bisson JI
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010204. PubMed ID: 27040448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.